Your browser doesn't support javascript.
loading
Recurrence, death, and secondary malignancy after ovarian conservation for young women with early-stage low-grade endometrial cancer.
Matsuo, Koji; Cripe, James C; Kurnit, Katherine C; Kaneda, Michiko; Garneau, Audrey S; Glaser, Gretchen E; Nizam, Aaron; Schillinger, Rachel M; Kuznicki, Michelle L; Yabuno, Akira; Yanai, Shiori; Garofalo, Denise M; Suzuki, Jiro; St Laurent, Jessica D; Yen, Ting-Tai; Liu, Annie Y; Shida, Masako; Kakuda, Mamoru; Oishi, Tetsuro; Nishio, Shin; Marcus, Jenna Z; Adachi, Sosuke; Kurokawa, Tetsuji; Ross, Malcolm S; Horowitz, Max P; Johnson, Marian S; Kim, Min K; Melamed, Alexander; Machado, Karime K; Yoshihara, Kosuke; Yoshida, Yoshio; Enomoto, Takayuki; Ushijima, Kimio; Satoh, Shinya; Ueda, Yutaka; Mikami, Mikio; Rimel, Bobbie J; Stone, Rebecca L; Growdon, Whitfield B; Okamoto, Aikou; Guntupalli, Saketh R; Hasegawa, Kosei; Shahzad, Mian M K; Im, Dwight D; Frimer, Marina; Gostout, Bobbie S; Ueland, Frederick R; Nagao, Shoji; Soliman, Pamela T; Thaker, Premal H.
Afiliación
  • Matsuo K; Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, University of Southern California, Los Angeles, CA, USA. Electronic address: koji.matsuo@med.usc.edu.
  • Cripe JC; Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Washington University School of Medicine, St. Louis, MO, USA.
  • Kurnit KC; Department of Gynecologic Oncology and Reproductive Medicine, MD-Anderson Cancer Center, University of Texas, Houston, TX, USA.
  • Kaneda M; Department of Gynecology, Hyogo Cancer Center, Hyogo, Japan.
  • Garneau AS; Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, University of Kentucky, Lexington, KY, USA.
  • Glaser GE; Division of Gynecologic Oncology, Department of Surgery, Mayo Clinic, Rochester, MN, USA.
  • Nizam A; Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Zucker School of Medicine at Hofstra/Northwell, Northwell Health, Long Island, NY, USA.
  • Schillinger RM; Gynecologic Oncology Center, Mercy Medical Center, Baltimore, MD, USA.
  • Kuznicki ML; Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Moffitt Cancer Center, University of South Florida, FL, USA.
  • Yabuno A; Department of Gynecologic Oncology, Saitama Medical University International Medical Center, Saitama, Japan.
  • Yanai S; Department of Obstetrics and Gynecology, Kurashiki Medical Center, Okayama, Japan.
  • Garofalo DM; Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, University of Colorado, Denver, CO, USA.
  • Suzuki J; Department of Obstetrics and Gynecology, Jikei University School of Medicine, Tokyo, Japan.
  • St Laurent JD; Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.
  • Yen TT; Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Johns Hopkins Medicine, Baltimore, MD, USA.
  • Liu AY; Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Cedars-Sinai Medical Center, Los Angeles, CA, USA.
  • Shida M; Department of Obstetrics and Gynecology, Tokai University School of Medicine, Kanagawa, Japan.
  • Kakuda M; Department of Obstetrics and Gynecology, Osaka University Graduate School of Medicine, Osaka, Japan.
  • Oishi T; Department of Obstetrics and Gynecology, Tottori University School of Medicine, Tottori, Japan.
  • Nishio S; Department of Obstetrics and Gynecology, Kurume University School of Medicine, Fukuoka, Japan.
  • Marcus JZ; Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Rutgers New Jersey Medical School, Newark, NJ, USA.
  • Adachi S; Department of Obstetrics and Gynecology, Niigata University School of Medicine, Niigata, Japan.
  • Kurokawa T; Department of Obstetrics and Gynecology, University of Fukui School of Medicine, Fukui, Japan.
  • Ross MS; Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Magee-Womens Hospital, University of Pittsburgh, Pittsburgh, PA, USA.
  • Horowitz MP; Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Cleveland Clinic, Cleveland, OH, USA.
  • Johnson MS; Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, University of Kentucky, Lexington, KY, USA.
  • Kim MK; Gynecologic Oncology Center, Mercy Medical Center, Baltimore, MD, USA.
  • Melamed A; Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.
  • Machado KK; Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Johns Hopkins Medicine, Baltimore, MD, USA.
  • Yoshihara K; Department of Obstetrics and Gynecology, Niigata University School of Medicine, Niigata, Japan.
  • Yoshida Y; Department of Obstetrics and Gynecology, University of Fukui School of Medicine, Fukui, Japan.
  • Enomoto T; Department of Obstetrics and Gynecology, Niigata University School of Medicine, Niigata, Japan.
  • Ushijima K; Department of Obstetrics and Gynecology, Kurume University School of Medicine, Fukuoka, Japan.
  • Satoh S; Department of Obstetrics and Gynecology, Tottori University School of Medicine, Tottori, Japan.
  • Ueda Y; Department of Obstetrics and Gynecology, Osaka University Graduate School of Medicine, Osaka, Japan.
  • Mikami M; Department of Obstetrics and Gynecology, Tokai University School of Medicine, Kanagawa, Japan.
  • Rimel BJ; Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Cedars-Sinai Medical Center, Los Angeles, CA, USA.
  • Stone RL; Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Johns Hopkins Medicine, Baltimore, MD, USA.
  • Growdon WB; Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.
  • Okamoto A; Department of Obstetrics and Gynecology, Jikei University School of Medicine, Tokyo, Japan.
  • Guntupalli SR; Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, University of Colorado, Denver, CO, USA.
  • Hasegawa K; Department of Gynecologic Oncology, Saitama Medical University International Medical Center, Saitama, Japan.
  • Shahzad MMK; Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Moffitt Cancer Center, University of South Florida, FL, USA.
  • Im DD; Gynecologic Oncology Center, Mercy Medical Center, Baltimore, MD, USA.
  • Frimer M; Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Zucker School of Medicine at Hofstra/Northwell, Northwell Health, Long Island, NY, USA.
  • Gostout BS; Division of Gynecologic Oncology, Department of Surgery, Mayo Clinic, Rochester, MN, USA.
  • Ueland FR; Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, University of Kentucky, Lexington, KY, USA.
  • Nagao S; Department of Gynecology, Hyogo Cancer Center, Hyogo, Japan.
  • Soliman PT; Department of Gynecologic Oncology and Reproductive Medicine, MD-Anderson Cancer Center, University of Texas, Houston, TX, USA.
  • Thaker PH; Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Washington University School of Medicine, St. Louis, MO, USA.
Gynecol Oncol ; 155(1): 39-50, 2019 10.
Article en En | MEDLINE | ID: mdl-31427143
OBJECTIVE: To examine the association between ovarian conservation and oncologic outcome in surgically-treated young women with early-stage, low-grade endometrial cancer. METHODS: This multicenter retrospective study examined women aged <50 with stage I grade 1-2 endometrioid endometrial cancer who underwent primary surgery with hysterectomy from 2000 to 2014 (US cohort n = 1196, and Japan cohort n = 495). Recurrence patterns, survival, and the presence of a metachronous secondary malignancy were assessed based on ovarian conservation versus oophorectomy. RESULTS: During the study period, the ovarian conservation rate significantly increased in the US cohort from 5.4% to 16.4% (P = 0.020) whereas the rate was unchanged in the Japan cohort (6.3-8.7%, P = 0.787). In the US cohort, ovarian conservation was not associated with disease-free survival (hazard ratio [HR] 0.829, 95% confidence interval [CI] 0.188-3.663, P = 0.805), overall survival (HR not estimated, P = 0.981), or metachronous secondary malignancy (HR 1.787, 95% CI 0.603-5.295, P = 0.295). In the Japan cohort, ovarian conservation was associated with decreased disease-free survival (HR 5.214, 95% CI 1.557-17.464, P = 0.007) and an increased risk of a metachronous secondary malignancy, particularly ovarian cancer (HR 7.119, 95% CI 1.349-37.554, P = 0.021), but was not associated with overall survival (HR not estimated, P = 0.987). Ovarian recurrence or metachronous secondary ovarian cancer occurred after a median time of 5.9 years, and all cases were salvaged. CONCLUSION: Our study suggests that adoption of ovarian conservation in young women with early-stage low-grade endometrial cancer varies by population. Ovarian conservation for young women with early-stage, low-grade endometrial cancer may be potentially associated with increased risks of ovarian recurrence or metachronous secondary ovarian cancer in certain populations; nevertheless, ovarian conservation did not negatively impact overall survival.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Ovario / Neoplasias Primarias Secundarias / Neoplasias Endometriales / Carcinoma Endometrioide / Tratamientos Conservadores del Órgano Tipo de estudio: Etiology_studies / Incidence_studies / Observational_studies / Risk_factors_studies Límite: Adult / Female / Humans País/Región como asunto: America do norte / Asia Idioma: En Revista: Gynecol Oncol Año: 2019 Tipo del documento: Article Pais de publicación: Estados Unidos

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Ovario / Neoplasias Primarias Secundarias / Neoplasias Endometriales / Carcinoma Endometrioide / Tratamientos Conservadores del Órgano Tipo de estudio: Etiology_studies / Incidence_studies / Observational_studies / Risk_factors_studies Límite: Adult / Female / Humans País/Región como asunto: America do norte / Asia Idioma: En Revista: Gynecol Oncol Año: 2019 Tipo del documento: Article Pais de publicación: Estados Unidos